About Cipla Diagnostics
Crafting Innovative Solutions to Enable Prompt and Effective Diagnosis
With expertise in developing high-quality, affordable tests coupled with our robust distribution network, Cipla Diagnostics enhances diagnostic accessibility and meets its vision of supporting patients across the healthcare spectrum.
CippointTM Comes With Unique Advantages
Multichannel (7 test channels + 1 emergency test channel)
Multiple test items can be tested at the same time
Constant
temperature (32° C)
Provides steady test environment
No Contamination
Waste container is set in the equipment
Easy & quick operation
Convenient & gives rapid test results in 3-15 min
- Dengue
- Malaria
- HIV
- HCV
- HBsAg
Rapid test, gives results in 15 mins
100% sensitivity and 100% specificity
Simultaneous detection of Dengue Ag and Ab
Detection of all stages of infection
CIPtest Dengue NS1 & IgG/IgM Rapid Test Card by CIPLA is a rapid, in-vitro immunochromatographic assay designed to detect IgG/IgM antibodies against dengue virus in human serum, plasma, or whole blood.
Worldwide
100-4000 million
cases of dengue occur each year1
in India
33
million
cases of dengue occur each year1
33
million
cases of dengue occur each year1
Rapid Antigen Testing for Dengue NSI & IgG/IgM - A Real-time Need
Download Detailed Brochure
Dengue NS1 & IgG/IgM Rapid Test Card
Alternative to microscopy
Fast results (15 min or less)
99% Sensitivity (Pf/Pv) & specificity
Cose effective
The CIPtest® Malaria pf/Pv Antigen rapid Test device by CIPLA is a single use, qualitative immunochromatographic test designed for proffesional use for differential diagnosis between pf-specific HRP2 antigen & pLDH antigen specific to Pv in human whole blood.
241 million
cases of malaria worldwide3%
of the global malaria burden in india
Rapid Antigen Testing for Malaria NS1 & igG/igM - A Real-time Need
Download Detailed Brochure
Malaria Pf & Pv Antigen Rapid Test Card
100% sensitivity and 99% specificity
Rapid test, gives results in 20 mins
Conventient and easy to use
Cose effective
CIPtest HIV 1 & 2 Rapid Test Card by CIPLA is a single-use, qualitative, immunochromatography test designed for professional use to detect antibodies to HIV 1 and 2 using whole blood, serum and plasma
35 million
cases of HIV worldwide2.4 million
cases of HIV in India
Rapid Antigen Testing for Dengue NSI & IgG/IgM - A Real-time Need
Download Detailed Brochure
HIV 1 & 2 Rapid Test Card
100% sensitivity and 99% specificity
Rapid test, gives results in 15 mins
Efficient with easy-to-interpret results
Accurate diagnosis of both symptomatic and asymptomatic cases
CIPtest HCV Rapid Test Card by CIPLA is a simple, single-use, immunochromatography test designed for the qualitative detection of antibodies specific to HCV using human whole blood, serum and plasma.
58 million
cases of HCV infection worldwide6-12 million
cases of HCV in India
Rapid Antigen Testing for HCV NSI & IgG/IgM - A Real-time Need
Download Detailed Brochure
HCV Rapid Test Card
100% sensitivity and 99% specificity
Simple, fast, and easy procedure
Ideal for use in a variety of healthcare settings
Ability to detect major HBsAg mutants
CIPtest HCV Rapid Test Card by CIPLA is a simple, single-use, immunochromatography test designed for the qualitative detection of antibodies specific to HCV using human whole blood, serum and plasma.
Estimated
300 million
cases of HBsAg worldwide
Estimated
40 million
cases of HCV in India
Rapid Antigen Testing for HBsAg NSI & IgG/IgM - A Real-time Need
Download Detailed Brochure
HBsAG Rapid Test Card
COVID-19 Antigen CARD TEST
Stability
Stable at 4-30oC
Test time
15-20 minutes
Pack size
25 tests
Shelf life
24 months
Advantages
User-friendly
Rapid
Easy
No instrument needed
Contact Us
Disclaimer
“The information provided on this website is intended solely for Healthcare Professionals and Laboratory Technicians for educational and informational purposes. It is not meant for self-diagnosis, treatment, or as a substitute for professional medical advice, diagnosis, or care by a qualified healthcare provider. The information, including text, graphics, and images, is not intended to promote, advertise, or endorse any specific product, treatment, or medical procedure. Images and visuals are for representation purposes only. Before giving your consent to share any personal data or to continue using this website, please review the Privacy Policy provided on cipla.com to understand how your information is collected, used, and protected”.
© Copyright 2022 Cipla Inc. All rights reserved
